Progress in inflammatory myopathies: Good but not good enough

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 5, 2001, Pages 569-573

  Dalakas, M C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CELL ADHESION MOLECULE; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MATRIX METALLOPROTEINASE INHIBITOR; METHOTREXATE; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CREATINE KINASE BLOOD LEVEL; CYTOTOXIC T LYMPHOCYTE; DERMATOMYOSITIS; DISEASE CLASSIFICATION; EDITORIAL; HUMAN; INCLUSION BODY MYOSITIS; LABORATORY TEST; MUSCLE BIOPSY; MYOPATHY; NOMENCLATURE; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; VIRUS INFECTION;

EID: 0035033787     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.5.569     Document Type: Editorial

References (37)

1. Polymyositis, dermatomyositis and inclusion-body myositis
2. Molecular immunology and genetics of inflammatory muscle diseases
3. Polymyositis and dermatomyositis
4. Inclusion body myositis: New concepts
5. Sporadic inclusion body myositis and hereditary inclusion-body myopathies
6. The polymyositis and dermatomyositis syndromes
7. Inclusion body myositis and myopathies
8. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis: Studies in 3 families
9. The spectrum of familial inclusion body myopathies in 13 families and description of a quadriceps sparing phenotype on non-Iranian Jews
10. Hereditary inclusion body myopathy maps to chromosome 9p1-a1
11. Immunopathogenesis of inflammatory mayopathies
12. Inclusion body myositis: Clinical and pathological boundaries
13. Idiopathic inflammatory myopathies
14. Amyloid filaments in inclusion body myositis: Novel findings provide insights into nature of filaments
15. Rimmed vacuoles with β-amyloid and ubiquitinated filamentous depositis in the muscles of patients with longstanding denervation (post-poliomyelitis muscular atrophy): Similarities with inclusion body myositis
16. Microvascular deposition of complement membrane attack complex in dermatomyositis
17. The immunobiology of muscle
18. Analysis of cytokine expression in muscle in inflammatory myopathies, dystrophy and non-weak controls
19. Cytokine expression profiles in idiopathies inflammatory myopathies
20. Transforming growth factor-B1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infilltrate
21. Analysis of T cell receptor repertiore of muscle infiltrating T lymphocytes in polymyositis: Restricted V a/b rearrangements may indicate antigen-driven selection
22. T cell receptor repertoire in polymyositis: Clonal expansion of autoaggresive CD8 T cells
23. Predominant I T cell receptor variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies
24. Human muscle cells express a functional costimulatory molecule distinct from B7.1 and B7.2 in vitro and in inflammatory lesions
25. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myospathies
26. Inclusion body myositis; Explanation for poor response to immunosuppressive therapy
27. Expression of matrix metallaproteinases in the muscle of patients with inflammatory myopathies
28. Inclusion body myositis in HIV-1 and HTLV-1 infected patients
29. AB-crystallin immunolocalization yields new insights into inclusion body myositis
30. The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositis
31. Treatment of inflammatory myopathies
32. A controlled trial of high-dose intravenous immunoglobulin infusions as treatment for dermatomyositis
33. High-dose immunoglobulin therapy in sporadic inclusion body myositis: A double-blind, placebo-controlled study
34. Combination of intravenous immunoglobulin in the treatment of patients with inclusion body myositis: A double blind placebo-controlled study
35. Sirollmus and ciclosporin for renal transplantation
36. Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy
37. Diseases progression in sporadic inclusion body myositis (s-IBM): Observation in 78 patients